The non-muscle actinopathy-associated mutation E334Q in cytoskeletal γ-actin perturbs interaction of actin filaments with myosin and ADF/cofilin family proteins.

actin actinopathy cofilin cytoskeleton human molecular biophysics myosin rare disease structural biology

Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
06 Mar 2024
Historique:
medline: 6 3 2024
pubmed: 6 3 2024
entrez: 6 3 2024
Statut: epublish

Résumé

Various heterozygous cytoskeletal γ-actin mutations have been shown to cause Baraitser-Winter cerebrofrontofacial syndrome, non-syndromic hearing loss, or isolated eye coloboma. Here, we report the biochemical characterization of human cytoskeletal γ-actin carrying mutation E334Q, a mutation that leads to a hitherto unspecified non-muscle actinopathy. Following expression, purification, and removal of linker and thymosin β4 tag sequences, the p.E334Q monomers show normal integration into linear and branched actin filaments. The mutation does not affect thermal stability, actin filament nucleation, elongation, and turnover. Model building and normal mode analysis predict significant differences in the interaction of p.E334Q filaments with myosin motors and members of the ADF/cofilin family of actin-binding proteins. Assays probing the interactions of p.E334Q filaments with human class 2 and class 5 myosin motor constructs show significant reductions in sliding velocity and actin affinity. E334Q differentially affects cofilin-mediated actin dynamics by increasing the rate of cofilin-mediated de novo nucleation of actin filaments and decreasing the efficiency of cofilin-mediated filament severing. Thus, it is likely that p.E334Q-mediated changes in myosin motor activity, as well as filament turnover, contribute to the observed disease phenotype.

Identifiants

pubmed: 38446501
doi: 10.7554/eLife.93013
pii: 93013
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : MA1081/23-1
Organisme : Deutsche Forschungsgemeinschaft
ID : MA1081/28-1
Organisme : Bundesministerium für Bildung und Forschung
ID : 01GM1922B
Organisme : Horizon 2020
ID : EJP RD COFUND 825575
Organisme : Hannover Medical School
ID : HiLF I
Organisme : Norddeutscher Verbund für Hoch- und Höchstleistungsrechnen
ID : nib00018

Informations de copyright

© 2023, Greve et al.

Déclaration de conflit d'intérêts

JG, AM, RH, TR, CT, ND, MT, DM No competing interests declared

Auteurs

Johannes N Greve (JN)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Anja Marquardt (A)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Robin Heiringhoff (R)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Theresia Reindl (T)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Claudia Thiel (C)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Nataliya Di Donato (N)

Department of Human Genetics, Hannover Medical School, Hannover, Germany.

Manuel H Taft (MH)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.

Dietmar J Manstein (DJ)

Institute for Biophysical Chemistry, Hannover Medical School, Fritz Hartmann Centre for Medical, Hannover, Germany.
Division for Structural Biochemistry, Hannover Medical School, Hannover, Germany.
RESiST, Cluster of Excellence 2155, Hannover Medical School, Hannover, Germany.

Classifications MeSH